Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03232294
Other study ID # 2017/222
Secondary ID
Status Completed
Phase N/A
First received July 25, 2017
Last updated July 25, 2017
Start date April 1, 2016
Est. completion date June 1, 2017

Study information

Verified date July 2017
Source Kayseri Education and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Abnormal fetal development such as macrosomia can cause some complications on both fetus and mother.The measurement of fetal anterior abdominal wall thickness (FAWT) is an easy examination that it can be obtained during an examination of a pregnant woman by ultrasound. Macrosomia for fetus can lead to some morbidities. It can affect perinatal outcome and increase childbirth complications and operative birth. There are some studies scrutinizing the relationship between FAWT and diabetes in the literature. However there are few studies which scrutinize effect of FAWT on both abnormal fetal development and adverse perinatal outcomes in non-diabetic pregnancies and non high risk pregnancies. Hence the investigators wonder if FAWT can anticipate birth-weight or macrosomic infant or perinatal outcome regarding with macrosomia in the second trimester.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date June 1, 2017
Est. primary completion date April 1, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

A total of 96 women with low risk pregnancy coming to our clinic for a routine antenatal examination in 26-28th gestational weeks were included to this study and performed 75 gr- oral glucose tolerance test (OGTT).

Exclusion Criteria:

The participants with a positive 75-g OGTT were excluded. Additionally those following criteria were accepted as the exclusion criteria of this study: hypertension, preeclampsia, diabetes, fetal distress, fetal anomaly, multiple pregnancy, preterm labor, preterm premature rupture of membrane, placenta previa, polyhydramnios and intrauterine fetal growth restriction.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Kayseri Education and Research Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary The relationship between fetal abdominal wall thickness and macrosomia 6 months
See also
  Status Clinical Trial Phase
Completed NCT00826904 - Regulation Of Maternal Fuel Supply And Neonatal Adiposity
Recruiting NCT06157684 - Timing of Ambulation and Infant Birth Weight in Gestational Diabetes N/A
Completed NCT02713568 - Estimation of Fetal Weight by MR Imaging to PREdict Neonatal MACROsomia (PREMACRO Study) N/A
Recruiting NCT03451838 - Prediction of Fetal Macrosomia by US
Recruiting NCT02473991 - Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight N/A
Unknown status NCT02371343 - Fish Oil Supplementation in Women With Gestational Diabetes N/A
Completed NCT02523222 - Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia N/A
Completed NCT03002246 - Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume
Recruiting NCT04399434 - Gut Microbiota, SCFAs and Glucolipid Metabolism in Pregnant Women With Abnormal Fetal Size and Their Newborns
Completed NCT00625781 - Treatment of Impaired Glucose Tolerance in Pregnancy N/A
Completed NCT00190320 - DAME: Induction of Labor or Waiting for Suspicion Fetal Macrosomia Phase 4
Not yet recruiting NCT06268392 - A Comparative Study of AI Methods for Fetal Diagnostic Accuracy in Ultrasound
Recruiting NCT06067685 - Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes